Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer

BACKGROUND: Osteoporosis is a skeletal disorder characterized by compromised bone strength, resulting in increased fracture risk. Patients with prostate cancer may have multiple risk factors contributing to bone fragility: advanced age, hypogonadism, and long-term use of androgen-deprivation therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Arif, Tripathi, Abhishek, Pieczonka, Christopher, Cope, Diane, McNatty, Andrea, Logothetis, Christopher, Guise, Theresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134041/
https://www.ncbi.nlm.nih.gov/pubmed/33028943
http://dx.doi.org/10.1038/s41391-020-00296-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134041/
https://www.ncbi.nlm.nih.gov/pubmed/33028943
http://dx.doi.org/10.1038/s41391-020-00296-y

Ejemplares similares